Brilliant, LLC – Trademark Portfolio
Entity Type: 16
Brilliant, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CALM ONE, EPIFOLIN, AIR+GUARD, and B BRILLIANT MOLECULAR NUTRITION. The owner is based in Cranston, RI.
50 Columbia Avenue
Cranston, RI 02905
Showing of trademarks Trademarks
Trademark Classifications
Brilliant, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Brilliant, LLC have?
Brilliant, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned.
What trademark classes does Brilliant, LLC file in?
Brilliant, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 43 (Hotels & Restaurants). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Brilliant, LLC's most well-known trademarks?
Brilliant, LLC's registered trademark portfolio includes well-known marks such as CALM ONE, EPIFOLIN, AIR+GUARD, and B BRILLIANT MOLECULAR NUTRITION. These are among 4 currently registered trademarks in the portfolio.
What is Brilliant, LLC's trademark registration success rate?
Brilliant, LLC has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.